Glucocorticoids—All-Rounders Tackling the Versatile Players of the Immune System
Cindy Strehl, Lisa Ehlers, Timo Gaber et al. · Frontiers in Immunology · 2019 · Review
Full textCC BY
Endocrinology, Diabetes and Metabolism
Filters2 filters applied
Status
Year
Readable here
Study type
Licence
The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats
Hsiang-Chun Lee, Yi-Lin Shiou, Shih-Jie Jhuo et al. · Cardiovascular Diabetology · 2019
Full textCC BY
The prevalence and increasing trends of overweight, general obesity, and abdominal obesity among Chinese adults: a repeated cross-sectional study
Yongjie Chen, Qin Peng, Yu Yang et al. · BMC Public Health · 2019
Full textCC BY
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
Fei Luo, Avash Das, Jingfei Chen et al. · Cardiovascular Diabetology · 2019 · Review
Full textCC BY
Health system performance for people with diabetes in 28 low- and middle-income countries: A cross-sectional study of nationally representative surveys
Jennifer Manne-Goehler, Pascal Geldsetzer, Kokou Agoudavi et al. · PLOS Medicine · 2019
Full textCC BY
Corrected Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond
Stephanie M. Gruss, Kunthea Nhim, Edward Gregg et al. · Current Diabetes Reports · 2019 · Review
Full textCC BY
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
Chenguang Li, Jie Zhang, Mei Xue et al. · Cardiovascular Diabetology · 2019
Full textCC BY
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer
Seong-Keun Yoo, Young Shin Song, Eun Kyung Lee et al. · Nature Communications · 2019
Full textCC BY
Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes
Victoria Tyndall, Roland H. Stimson, Nicola N. Zammitt et al. · Diabetologia · 2019
Full textCC BY
The Discovery and Development of Liraglutide and Semaglutide
Lotte Bjerre Knudsen, Jesper Lau · Frontiers in Endocrinology · 2019 · Review
Full textCC BY
Dietary Fructose and the Metabolic Syndrome
Marja-Riitta Taskinen, Chris J Packard, Jan Borén · Nutrients · 2019 · Review
Full textCC BY
Corrected Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
Paul J. Connelly, E. Marie Freel, Colin Perry et al. · Hypertension · 2019 · Review
Full textCC BY
The Triglyceride-Glucose Index Predicts Coronary Artery Disease Severity and Cardiovascular Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
Qi Mao, Denglu Zhou, Youmei Li et al. · Disease Markers · 2019
Full textCC BY
Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol
Danja J. Den Hartogh, Evangelia Tsiani · Biomolecules · 2019 · Review
Full textCC BY
Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial
Naveed Sattar, David Fitchett, Stefan Hantel et al. · Diabetologia · 2018 · Randomised trial
Full textCC BY
Corrected GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data
Andrei C. Sposito, Otávio Berwanger, Luiz Sérgio F. de Carvalho et al. · Cardiovascular Diabetology · 2018 · Review
Full textCC BY
Iodine as Essential Nutrient during the First 1000 Days of Life
Inés Velasco, Sarah Bath, Margaret Rayman · Nutrients · 2018 · Review
Full textCC BY
Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma
Priyanka C. Iyer, Ramona Dadu, Maria Gule-Monroe et al. · Journal for ImmunoTherapy of Cancer · 2018
Full textCC BY
Trends in Diabetic Ketoacidosis Hospitalizations and In-Hospital Mortality — United States, 2000–2014
Stephen R. Benoit, Yan Zhang, Linda S. Geiss et al. · MMWR. Morbidity and Mortality Weekly Report · 2018
Full textCC BY
Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
Eleni Bekiari, Konstantinos Kitsios, Hood Thabit et al. · BMJ · 2018 · Meta-analysis
Full textCC BY